tumor sequencing

Feb 26, 2021

Natera Launches Tumor Genomic Profiling Assay, Expects Reproductive Health to Break Even This Year
Premium

Feb 5, 2021

Guardant Health Turns to Tumor Tissue Sequencing to Broaden Offering
Premium

Oct 8, 2020

Germline Genetic Testing After Tumor Sequencing Can Uncover Clinically Actionable Variants

Jul 15, 2020

Patient Education Project Identifies Need for Consistent Terms in Cancer Testing

Jun 15, 2020

Dante Labs, Cambridge Cancer Genomics, Nonacus Collaborate to Build Tumor Profiling Service

Feb 29, 2020

NantHealth Q4 Revenues Grow 6 Percent

Feb 6, 2020

Despite Barriers, Labs Starting to Report Suspected Cancer Risk Mutations Seen in Tumor Testing

Nov 19, 2019

Despite FDA Clearance for NantHealth Test, Benefits of TMB Biomarker Unclear
Premium

Nov 12, 2019

FDA Clears NantHealth Tumor-Normal Whole-Exome Test

Nov 7, 2019

NantHealth Q3 Revenues Increase Marginally

Aug 8, 2019

NantHealth Q2 Revenues Grow 17 Percent

May 9, 2019

NantHealth Q1 Revenues Increase 6 Percent

Mar 28, 2019

NantHealth Q4 Revenues Increase 3 Percent

Mar 27, 2019

Nationwide Children's Aims to Demonstrate Benefits of Comprehensive Cancer Sequencing
Premium

Jan 11, 2019

Foundation Medicine Says Tumor Mutational Burden Reporting Issue on CDx Test Is Resolved

Nov 16, 2018

NantHealth Q3 Revenues Grow 2 Percent as Reimbursement Issues Frustrate

Sep 27, 2018

Quest Buys Anatomic Pathology Firm PhenoPath

Jul 19, 2018

Garvan Institute's Australian Genomic Cancer Medicine Program Receives A$50M in Government Funding

Jul 18, 2018

Foundation Medicine, Guardant Health Settle Patent Infringement Suit

May 3, 2018

AMP-Led Project Compares Bioinformatics Pipelines for Analyzing Cancer Panel Data